483 related articles for article (PubMed ID: 17103264)
41. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computerized tomography, and physical examination.
Sardi A; Agnone CM; Nieroda CA; Mojzisik C; Hinkle G; Ferrara P; Farrar WB; Bolton J; Thurston MO; Martin EW
South Med J; 1989 Oct; 82(10):1235-44. PubMed ID: 2799440
[TBL] [Abstract][Full Text] [Related]
42. Biliary carcinoembryonic antigen levels can predict metachronous liver metastasis of colorectal cancer.
Ishida H; Yoshinaga K; Gonda T; Ando M; Hojo I; Fukunari H; Iwama T; Mishima Y
Anticancer Res; 2000; 20(1B):523-6. PubMed ID: 10769718
[TBL] [Abstract][Full Text] [Related]
43. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer.
Iwanicki-Caron I; Di Fiore F; Roque I; Astruc E; Stetiu M; Duclos A; Tougeron D; Saillard S; Thureau S; Benichou J; Paillot B; Basuyau JP; Michel P
J Clin Oncol; 2008 Aug; 26(22):3681-6. PubMed ID: 18669452
[TBL] [Abstract][Full Text] [Related]
44. [Value of blood assay of tumor markers for detecting recurrence of colorectal cancer].
Pélissier E; Bosset JF; Meneveau N
Bull Cancer; 1994 Dec; 81(12):1050-6. PubMed ID: 7742592
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
46. [Measurement of serum protein-bound hexose--an aid in the diagnosis and after-care of colorectal cancers?].
Putzki H; Reichert B; Hue M
Zentralbl Chir; 1992; 117(6):331-3. PubMed ID: 1519392
[TBL] [Abstract][Full Text] [Related]
47. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study.
Tuech JJ; Pessaux P; Regenet N; Daver A; Lorimier G; Bergamaschi R; Arnaud JP
J Surg Oncol; 2004 Oct; 88(1):27-31. PubMed ID: 15384059
[TBL] [Abstract][Full Text] [Related]
48. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
49. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
[TBL] [Abstract][Full Text] [Related]
50. Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels.
Wang JY; Lin SR; Wu DC; Lu CY; Yu FJ; Hsieh JS; Cheng TL; Koay LB; Uen YH
Clin Cancer Res; 2007 Apr; 13(8):2406-13. PubMed ID: 17406027
[TBL] [Abstract][Full Text] [Related]
51. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer.
Irvine T; Scott M; Clark CI
Colorectal Dis; 2007 Jul; 9(6):527-31. PubMed ID: 17573747
[TBL] [Abstract][Full Text] [Related]
52. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A
Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
[TBL] [Abstract][Full Text] [Related]
53. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
[TBL] [Abstract][Full Text] [Related]
54. [Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers].
Stapel A; Franke U; Putzki H
Zentralbl Chir; 1992; 117(2):77-80. PubMed ID: 1315472
[TBL] [Abstract][Full Text] [Related]
55. Detection of carcinoembryonic antigen messenger RNA-expressing cells in portal and peripheral blood during surgery does not influence relapse in colorectal cancer.
Sadahiro S; Suzuki T; Ishikawa K; Saguchi T; Maeda Y; Yasuda S; Makuuchi H; Yurimoto S; Murayama C
Ann Surg Oncol; 2005 Dec; 12(12):988-94. PubMed ID: 16244799
[TBL] [Abstract][Full Text] [Related]
56. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
Grotowski M; Maruszyński M; Piechota W
Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
[TBL] [Abstract][Full Text] [Related]
57. An evaluation of the clinical usefulness of CEA in colorectal cancer.
Torosian MH; Daly JM
Oncology (Williston Park); 1991 May; 5(5):41-4; discussion 44, 49-50, 52-3. PubMed ID: 1832005
[TBL] [Abstract][Full Text] [Related]
58. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
Gebauer G; Müller-Ruchholtz W
Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011
[TBL] [Abstract][Full Text] [Related]
59. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer].
Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139
[TBL] [Abstract][Full Text] [Related]
60. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
